Literature DB >> 16227111

Unmasked adult-onset urea cycle disorders in the critical care setting.

Marshall L Summar1, Frederick Barr, Sheila Dawling, Wendy Smith, Brendan Lee, Rani H Singh, William J Rhead, Lisa Sniderman King, Brian W Christman.   

Abstract

Most often, urea cycle disorders have been described as acute onset hyperammonemia in the newborn period; however, there is a growing awareness that urea cycle disorders can present at almost any age, frequently in the critical care setting. This article presents three cases of adult-onset hyperammonemia caused by inherited defects in nitrogen processing in the urea cycle, and reviews the diagnosis, management, and pathophysiology of adult-onset urea cycle disorders. Individuals who have milder molecular urea cycle defects can lead a relatively normal life until a severe environmental stress triggers a hyperammonemic crisis. Comorbid conditions such as physical trauma often delay the diagnosis of the urea cycle defect. Prompt recognition and treatment are essential in determining the outcome of these patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227111     DOI: 10.1016/j.ccc.2005.05.002

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  33 in total

1.  Determination of mutation patterns in human ornithine transcarbamylase precursor.

Authors:  Shaomin Yan; Guang Wu
Journal:  J Clin Monit Comput       Date:  2009-02-10       Impact factor: 2.502

2.  Barriers to transplantation in adults with inborn errors of metabolism.

Authors:  S M Sirrs; H Faghfoury; E M Yoshida; T Geberhiwot
Journal:  JIMD Rep       Date:  2012-08-22

3.  Treatment of Severe Protein Malnutrition After Bariatric Surgery.

Authors:  Carlijn Kuin; Floor den Ouden; Hans Brandts; Laura Deden; Eric Hazebroek; Marcel van Borren; Hans de Boer
Journal:  Obes Surg       Date:  2019-10       Impact factor: 4.129

4.  Early liver transplantation in neonatal-onset and moderate urea cycle disorders may lead to normal neurodevelopment.

Authors:  Jun Kido; Shirou Matsumoto; Hiroshi Mitsubuchi; Fumio Endo; Kimitoshi Nakamura
Journal:  Metab Brain Dis       Date:  2018-06-11       Impact factor: 3.584

5.  Successful management of refractory intracranial hypertension from acute hyperammonemic encephalopathy in a woman with ornithine transcarbamylase deficiency.

Authors:  Linda C Wendell; Amir Khan; Jonathan Raser; Shih-Shan Lang; Neil Malhotra; W Andrew Kofke; Peter LeRoux; Soojin Park; Joshua M Levine
Journal:  Neurocrit Care       Date:  2010-08       Impact factor: 3.210

6.  Nonhepatic hyperammonemic encephalopathy due to undiagnosed urea cycle disorder.

Authors:  Tashfeen Mahmood; Kenneth Nugent
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-07

7.  Sodium benzoate for treatment of hepatic encephalopathy.

Authors:  Michael L Misel; Robert G Gish; Heather Patton; Michel Mendler
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-04

8.  Significant hepatic involvement in patients with ornithine transcarbamylase deficiency.

Authors:  Renata C Gallagher; Christina Lam; Derek Wong; Stephen Cederbaum; Ronald J Sokol
Journal:  J Pediatr       Date:  2014-01-30       Impact factor: 4.406

Review 9.  The Role of RRT in Hyperammonemic Patients.

Authors:  Shruti Gupta; Andrew Z Fenves; Robert Hootkins
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-19       Impact factor: 8.237

10.  Hemodialysis for hyperammonemia associated with ornithine transcarbamylase deficiency.

Authors:  Jacob F Collen; Nealanjon P Das; Jonathan M Koff; Robert T Neff; Kevin C Abbott
Journal:  Appl Clin Genet       Date:  2008-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.